Roche Abandons New Diabetes Drug
Development of the drug, aleglitazar, was discontinued after Roche cited safety reasons and questions over its effectiveness. [Source]
Publication Date:Origin: nytimes.com
Category: Drugs (Pharmaceuticals)
Topics: Roche, , effectiveness, questions, reasons, safety, cited, discontinued, aleglitazar, Development, Diabetes, Abandons
Source: http://www.nytimes.com/2013/07/11/business/roche-abandons-new-diabetes-drug.html?partner=rss&emc=rss